Patents by Inventor Timothy Martin Kelly

Timothy Martin Kelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Downstream Processing of an Alkaline Phosphatase
    Publication number: 20200063112
    Abstract: The invention relates to the field of downstream processing (DSP) of an alkaline phosphatase (AP). More specifically, it relates to a method for reducing host cell protein content in a composition comprising AP. The invention further relates to a composition comprising an AP and a reduced content of a host cell protein.
    Type: Application
    Filed: September 4, 2019
    Publication date: February 27, 2020
    Applicant: AM-Pharma B.V.
    Inventors: Luigi Johannes Cornelius JONK, Stephen Edward CONNOR, Erik Jan VAN-DEN BERG, Andrea VAN ELSAS, Abhinav Alok SHUKLA, Heather Bethea HORNE, Susan COOK, Timothy Martin KELLY, Victoria Anne DOWLING, Mialy Fanjamalala RAMAROSON
  • Downstream processing of an alkaline phosphatase
    Patent number: 10570380
    Abstract: The invention relates to the field of downstream processing (DSP) of an alkaline phosphatase (AP). More specifically, it relates to a method for reducing host cell protein content in a composition comprising AP. The invention further relates to a composition comprising an AP and a reduced content of a host cell protein.
    Type: Grant
    Filed: January 26, 2015
    Date of Patent: February 25, 2020
    Assignee: AM-PHARMA B.V.
    Inventors: Luigi Johannes Cornelius Jonk, Stephen Edward Connor, Erik Jan Van Den Berg, Andrea Van Elsas, Abhinav Alok Shukla, Heather Bethea Horne, Susan Cook, Timothy Martin Kelly, Victoria Anne Dowling, Mialy Fanjamalala Ramaroson
  • ANTIBODY FORMULATIONS
    Publication number: 20190338036
    Abstract: Formulations of anti-VLA-1 antibodies are described.
    Type: Application
    Filed: April 24, 2019
    Publication date: November 7, 2019
    Inventors: Adam Jeremy Fowler, Craig Michael Bowe, Wayne Curtis Yount, Nathan Jeremy Cobb, Timothy Martin Kelly
  • ANTI-VLA1 (CD49A) ANTIBODY PHARMACEUTICAL COMPOSITIONS
    Publication number: 20190194331
    Abstract: Formulations of anti-VLA-1 antibodies are described.
    Type: Application
    Filed: December 20, 2018
    Publication date: June 27, 2019
    Inventors: Adam Jeremy Fowler, Craig Michael Bowe, Wayne Curtis Yount, Nathan Jeremy Cobb, Timothy Martin Kelly
  • Antibody formulations
    Patent number: 10316095
    Abstract: Formulations of anti-VLA-1 antibodies are described.
    Type: Grant
    Filed: February 14, 2013
    Date of Patent: June 11, 2019
    Assignee: Santarus, Inc.
    Inventors: Adam Jeremy Fowler, Craig Michael Bowe, Wayne Curtis Yount, Nathan Jeremy Cobb, Timothy Martin Kelly
  • Anti-VLA1 (CD49A) antibody pharmaceutical compositions
    Patent number: 10160808
    Abstract: Formulations of anti-VLA-1 antibodies are described.
    Type: Grant
    Filed: February 14, 2013
    Date of Patent: December 25, 2018
    Assignee: Santarus, Inc.
    Inventors: Adam Jeremy Fowler, Craig Michael Bowe, Wayne Curtis Yount, Nathan Jeremy Cobb, Timothy Martin Kelly
  • Downstream Processing of an Alkaline Phosphatase
    Publication number: 20170009217
    Abstract: The invention relates to the field of downstream processing (DSP) of an alkaline phosphatase (AP). More specifically, it relates to a method for reducing host cell protein content in a composition comprising AP. The invention further relates to a composition comprising an AP and a reduced content of a host cell protein.
    Type: Application
    Filed: January 26, 2015
    Publication date: January 12, 2017
    Applicant: AM-PHARMA B.V.
    Inventors: Luigi Johannes Cornelius JONK, Stephen Edward CONNER, Erik Jan VAN DEN BERG, Andrea VAN ELSAS, Abhinav Alok SHUKLA, Heather Bethea HORNE, Susan COOK, Timothy Martin KELLY, Victoria Anne DOWLING, Mialy Fanjamalala RAMAROSON
  • ANTI-VLA1 (CD49A) ANTIBODY PHARMACEUTICAL COMPOSITIONS
    Publication number: 20160017043
    Abstract: Formulations of anti-VLA-1 antibodies are described.
    Type: Application
    Filed: February 14, 2013
    Publication date: January 21, 2016
    Inventors: Adam Jeremy Fowler, Craig Michael Bowe, Wayne Curtis Yount, Nathan Jeremy Cobb, Timothy Martin Kelly
  • ANTIBODY FORMULATIONS
    Publication number: 20140010827
    Abstract: Formulations of anti-VLA-1 antibodies are described.
    Type: Application
    Filed: August 30, 2013
    Publication date: January 9, 2014
    Applicant: SANTARUS, INC.
    Inventors: Adam Jeremy Fowler, Craig Michael Bowe, Wayne Curtis Yount, Nathan Jeremy Cobb, Timothy Martin Kelly